In its comments to the Senate Finance Committee, the organization outlined the impact that the BAT would have on pharmacies and patients.
NPA’s industry resources, along with pro-active advocacy efforts, continue to attract new members who know that the industry’s well being requires that they become involved, the asssociation stated.
Gilead’s hepatitis C treatment Vosevi and Puma Biotechnology’s breast cancer drug Nerlynx both earned Food and Drug Administration approval this week.
Jean Coutu founder Jean Coutu spoke out regarding negotiations with Quebec around dispensing fees, according to a report published last week by Canada's Bell Media. Jean Coutu earlier this year agreed to surrender $300 million in collected dispensing fees in return for smaller manufacturer rebates that cut into pharmacy operating margins. "It is an average of $100,000 for each of our locations," Coutu told shareholders BellMedia reported. "It was extremely difficult to digest." (Bell Media)
The pilot, included in the 2017 federal budget plan, would allow TRICARE beneficiaries to get their prescriptions from retail pharmacies, rather than by mail order or through military treatment facilities.
The new tool is available to members of AmerisourceBergen’s pharmacy services administrative organization, Elevate Provider Network, who take advantage of its advanced features.
Mike Hotra joins the organization as VP of its public affairs team, and Ken McKay is the advocacy organization’s new VP state government affairs.
Over-the-counter hearing aid devices are expected to range in price from $100 to $600.
The term “medical food” is defined by Congress as “a food which is formulated to be consumed [orally] or administered internally under the supervision of a physician."
Rachel Sher was most recently a senior policy analyst in the Food and Drug Administration’s Office of Policy.